A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice

Tuberculosis (TB) is an infectious disease that seriously affects human health. Until now, the only anti-TB vaccine approved for use is the live attenuated Mycobacterium bovis (M. bovis) vaccine — BCG vaccine, but its protective efficacy is relatively low and does not provide satisfactory protection...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jinjie, Fan, Xueting, Luan, Xiuli, Wang, Ruihuan, Cao, Bin, Qian, Chengyu, Li, Guilian, Li, Machao, Zhao, Xiuqin, Liu, Haican, Wan, Kanglin, Yuan, Xiuqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161251/
https://www.ncbi.nlm.nih.gov/pubmed/37153610
http://dx.doi.org/10.3389/fimmu.2023.1138818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161251/
https://www.ncbi.nlm.nih.gov/pubmed/37153610
http://dx.doi.org/10.3389/fimmu.2023.1138818

Ejemplares similares